Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin receptor substrate 1 (IRS-1) is a key intracellular signaling adaptor protein that mediates insulin and IGF-1 signaling. It is activated by tyrosine phosphorylation upon receptor stimulation, which creates docking sites for SH2 domain-containing proteins, leading to activation of downstream pathways like PI3K/Akt and MAPK/ERK. Serine/threonine phosphorylation negatively regulates IRS-1 function, contributing to insulin resistance in conditions like obesity and type II diabetes.
Modulation of tyrosine/serine phosphorylation to enhance or inhibit downstream signaling pathways (PI3K/Akt, MAPK/ERK)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin Receptor Substrate 1 (IRS1).